International Physicians Delphi Survey: Managing Patients With IgA Nephropathy
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F22%3A10448755" target="_blank" >RIV/00064165:_____/22:10448755 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11110/22:10448755
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=jIwVBHu.X4" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=jIwVBHu.X4</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ekir.2022.05.022" target="_blank" >10.1016/j.ekir.2022.05.022</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
International Physicians Delphi Survey: Managing Patients With IgA Nephropathy
Popis výsledku v původním jazyce
IgA nephropathy (IgAN) typically is a slowly progressing disease, with 10% to 60% of patients developing chronic kidney failure within 10 years. Practice guidelines (e.g., Kidney Disease: Improving Global Outcomes [KDIGO]) are available, but it is unknown how uniformly nephrologists in different countries agree with and may follow these guidelines. The Delphi Focal Segmental Glomerulosclerosis and IgA Nephropathy Experts: Physicians (DEFINE: Physicians) study sought to capture nephrologist opinions on IgAN pathophysiology, diagnosis, treatment, and monitoring. In this 2-round Delphi survey, agreement with 20 statements about IgAN was scored by adult and pediatric nephrologists from 7 countries using a 1 to 9 Likert scale (9 = strongly agree). Moderate versus high consensus was defined as 75% to 89% versus >=90% of participants scoring 7 to 9, respectively. Methods and participant characteristics are detailed in the Supplementary Materials.
Název v anglickém jazyce
International Physicians Delphi Survey: Managing Patients With IgA Nephropathy
Popis výsledku anglicky
IgA nephropathy (IgAN) typically is a slowly progressing disease, with 10% to 60% of patients developing chronic kidney failure within 10 years. Practice guidelines (e.g., Kidney Disease: Improving Global Outcomes [KDIGO]) are available, but it is unknown how uniformly nephrologists in different countries agree with and may follow these guidelines. The Delphi Focal Segmental Glomerulosclerosis and IgA Nephropathy Experts: Physicians (DEFINE: Physicians) study sought to capture nephrologist opinions on IgAN pathophysiology, diagnosis, treatment, and monitoring. In this 2-round Delphi survey, agreement with 20 statements about IgAN was scored by adult and pediatric nephrologists from 7 countries using a 1 to 9 Likert scale (9 = strongly agree). Moderate versus high consensus was defined as 75% to 89% versus >=90% of participants scoring 7 to 9, respectively. Methods and participant characteristics are detailed in the Supplementary Materials.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30217 - Urology and nephrology
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2022
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Kidney International Reports
ISSN
2468-0249
e-ISSN
2468-0249
Svazek periodika
7
Číslo periodika v rámci svazku
9
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
5
Strana od-do
2076-2080
Kód UT WoS článku
000863107700016
EID výsledku v databázi Scopus
2-s2.0-85132801733